Redhawk Wealth Advisors’s Microbot Medical MBOT Stock Holding History

Redhawk Wealth Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	–	–	304
2019 Q2	$0	Buy	+1	New	+$7	﹤0.01%	482

Other funds holding MBOT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Redhawk Wealth Advisors's MBOT Position: Q3 2019 in Review

Redhawk Wealth Advisors sold out of Microbot Medical (MBOT) in Q3 2019, closing a stake of 1 share.

Redhawk Wealth Advisors first reported a position in MBOT in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 31 funds tracked by Wall St. Rank hold MBOT as of Q3 2019.

Redhawk Wealth Advisors reported no remaining Microbot Medical position as of Q3 2019 after selling out during the quarter.
Redhawk Wealth Advisors sold 1 Microbot Medical share in Q3 2019.
Redhawk Wealth Advisors first reported a position in Microbot Medical in Q2 2019 and held it in 1 quarter.
Redhawk Wealth Advisors's Microbot Medical position peaked at $0 in Q2 2019.
31 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2019.

Based on Redhawk Wealth Advisors's 13F filing for Q3 2019, filed 4 Oct 2019.